• Categorize

  Pfizer's heavy reliance on its COVID-19 vaccine and Paxlovid antiviral drug for growth could pose a risk to its future revenue stream if the pandemic subsides or new, more effective treatments emerge.

  70% · Weight
• Categorize

  The company's large size and complex organizational structure can make it difficult to adapt quickly to changing market conditions or execute strategic initiatives effectively.

  60% · Weight